Enterovirus D type 111 Genetically and Phenotypically Characterized
By LabMedica International staff writers Posted on 06 Nov 2019 |
Image: The High Pure Viral RNA Kit is for general laboratory use and purifies viral RNA from a variety of samples such as serum and plasma (Photo courtesy of Roche Diagnostics).
Members of the species Enterovirus D (EV-D) remain poorly studied. The two first EV-D types (EV-D68 and EV-D70) have regularly caused outbreaks in humans since their discovery five decades ago but have been neglected until the recent occurrence of severe respiratory diseases due to EV-D68.
The three other known EV-D types (EV-D94, EV-D111 and EV-D120) were discovered in the 2000s-2010s in Africa and have never been observed elsewhere. One strain of EV-D111 and all known EV-D120s were detected in stool samples of wild non-human primates, suggesting that these viruses could be zoonotic viruses.
Virologists at the Institut Pasteur (Paris, France) and their international colleagues isolated four EV-D111s that had been in cell cultures from stool samples of children with acute flaccid paralysis in the framework of poliovirus surveillance. Viral RNAs were extracted from cell culture supernatants with the High Pure Viral RNA kit (Roche Diagnostics, Risch-Rotkreuz, Switzerland). Virus genomes were amplified by reverse transcription polymerase chain reaction (RT-PCR) with generic primers and the products were sequenced using Illumina NextSeq HiSeq (Illumina, San Diego, CA, USA).
The acid sensitivity assay was performed on EV-D111 OUP-05-059, using EV-D68 Fermon and EV-D70 J670/71, which are known to be acid-sensitive and acid-resistant, respectively as controls. The ability of EV-D111 OUP-05-059 to produce cytopathic effect in different cell lines was assessed in 96-well plates. To determine whether EV-D111 grows in L cells, L cells were cultivated in 24-well plates until confluence. Anti-CD155 monoclonal antibody were produced and used for immunofluorescence and infectivity inhibition assays.
The team observed that the EV-D111 strains from human samples and the unique simian EV-D111 strain were not phylogenetically distinct, thus suggesting a recent zoonotic transmission. They also discovered evidences of probable intertypic genetic recombination events between EV-D111s and EV-D94s. As recombination can only happen in co-infected cells, this suggests that EV-D94s and EV-D111s share common replication sites in the infected hosts. These sites could be located in the gut since the phenotypic analysis they performed showed that, contrary to EV-D68s and like EV-D94s, EV-D111s are resistant to acid pH.
The scientists also found that EV-D111s induce strong cytopathic effects on L20B cells, a cell line routinely used to specifically detect polioviruses. An active circulation of EV-D111s among humans could then induce a high number of false-positive detection of polioviruses, which could be particularly problematic in Central Africa, where EV-D111 circulates and which is a key region for poliovirus eradication. The authors concluded that their results show that EV-D111s are probably enteric viruses and evolve by exchanging genetic sequences with EV-D94.The study was published on October 17, 2019, in the journal PLOS Neglected Tropical Diseases.
Related Links:
Institut Pasteur
Roche Diagnostics
Illumina
The three other known EV-D types (EV-D94, EV-D111 and EV-D120) were discovered in the 2000s-2010s in Africa and have never been observed elsewhere. One strain of EV-D111 and all known EV-D120s were detected in stool samples of wild non-human primates, suggesting that these viruses could be zoonotic viruses.
Virologists at the Institut Pasteur (Paris, France) and their international colleagues isolated four EV-D111s that had been in cell cultures from stool samples of children with acute flaccid paralysis in the framework of poliovirus surveillance. Viral RNAs were extracted from cell culture supernatants with the High Pure Viral RNA kit (Roche Diagnostics, Risch-Rotkreuz, Switzerland). Virus genomes were amplified by reverse transcription polymerase chain reaction (RT-PCR) with generic primers and the products were sequenced using Illumina NextSeq HiSeq (Illumina, San Diego, CA, USA).
The acid sensitivity assay was performed on EV-D111 OUP-05-059, using EV-D68 Fermon and EV-D70 J670/71, which are known to be acid-sensitive and acid-resistant, respectively as controls. The ability of EV-D111 OUP-05-059 to produce cytopathic effect in different cell lines was assessed in 96-well plates. To determine whether EV-D111 grows in L cells, L cells were cultivated in 24-well plates until confluence. Anti-CD155 monoclonal antibody were produced and used for immunofluorescence and infectivity inhibition assays.
The team observed that the EV-D111 strains from human samples and the unique simian EV-D111 strain were not phylogenetically distinct, thus suggesting a recent zoonotic transmission. They also discovered evidences of probable intertypic genetic recombination events between EV-D111s and EV-D94s. As recombination can only happen in co-infected cells, this suggests that EV-D94s and EV-D111s share common replication sites in the infected hosts. These sites could be located in the gut since the phenotypic analysis they performed showed that, contrary to EV-D68s and like EV-D94s, EV-D111s are resistant to acid pH.
The scientists also found that EV-D111s induce strong cytopathic effects on L20B cells, a cell line routinely used to specifically detect polioviruses. An active circulation of EV-D111s among humans could then induce a high number of false-positive detection of polioviruses, which could be particularly problematic in Central Africa, where EV-D111 circulates and which is a key region for poliovirus eradication. The authors concluded that their results show that EV-D111s are probably enteric viruses and evolve by exchanging genetic sequences with EV-D94.The study was published on October 17, 2019, in the journal PLOS Neglected Tropical Diseases.
Related Links:
Institut Pasteur
Roche Diagnostics
Illumina
Latest Microbiology News
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia
- Rapid AST Platform Provides Targeted Therapeutic Results Days Faster Than Current Standard of Care
- New Analysis Method Detects Pathogens in Blood Faster and More Accurately by Melting DNA
- Rapid Sepsis Test Delivers Two Days Faster Results